iCAD to Participate at the Imagine AI + Healthcare Investor Summit

NASHUA, N.H.,
Dec. 06, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that Stacey Stevens, President and incoming Chief Executive Officer,
will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare
Investor Summit being hosted by Oppenheimer in partnership with the Alliance
for AI in Healthcare (AAIH).

Oppenheimer’s
Imagine AI + Healthcare Investor Summit
Date: Tuesday, December 7th

Time: 11:00 a.m. to 11:20 a.m.
ET
Registration Link

About
iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader
providing innovative cancer detection and therapy solutions. For more
information, visit www.icadmed.com.

Contact:

Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor
Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com